Company / Shareholders' Equity
MUSTANG BIO, INC. Shareholders' Equity History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$36.4M
FY2019
5-year range
-$4.1M / $59.8M
FY2016-FY2019
Trend
-39.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $24M to $36M over the past 2 years.
Based on SEC 10-K filings.
$36M in FY2019.
Improved from $24M to $36M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, shareholders' equity decreased 39.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.37 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $36.4M | -39.2% |
| FY2018 | $59.8M | +146.5% |
| FY2017 | $24.3M | +687.9% |
| FY2016 | -$4.1M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026